Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation

ClinicalTrials.gov ID: NCT03930732

Public ClinicalTrials.gov record NCT03930732. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 4:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation

Study identification

NCT ID
NCT03930732
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
939 participants

Conditions and interventions

Interventions

  • Dupilumab SAR231893 Drug
  • Inhaled Corticosteroid Drug
  • Inhaled Long-Acting Beta Agonist Drug
  • Inhaled Long-Acting Muscarinic Antagonist Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 14, 2019
Primary completion
Feb 7, 2023
Completion
May 1, 2023
Last update posted
Feb 27, 2024

2019 – 2023

United States locations

U.S. sites
51
U.S. states
20
U.S. cities
49
Facility City State ZIP Site status
SEC Clinical Research, LLC-Site Number:8400030 Andalusia Alabama 36420
Clinical Research Center of Alabama, LLC-Site Number:8400041 Birmingham Alabama 35209-6802
UAB Lung Health Center-Site Number:8400013 Birmingham Alabama 35294
SEC Clinical Research, LLC-Site Number:8400059 Dothan Alabama 36303
Pulmonary Associates of Mobile, P.C.-Site Number:8400057 Mobile Alabama 36608
Asthma and Allergy Associates, PC-Site Number:8400034 Colorado Springs Colorado 80907
Clinical Research Of West Florida Inc-Site Number:8400010 Clearwater Florida 33765
Finlay Medical Research-Site Number:8400014 Greenacres City Florida 33467
Project 4 research, Inc.-Site Number:8400023 Miami Florida 33125
Finlay Medical Research-Site Number:8400062 Miami Florida 33126
Renstar Medical Research-Site Number:8400051 Ocala Florida 34470
Florida Institute for Clinical Research, LLC-Site Number:8400029 Orlando Florida 32825
Emerald Coast Research Associates-Site Number:8400032 Panama City Florida 32405
Sarasota Clinical Research-Site Number:8400026 Sarasota Florida 34239
VitaLink research-Hamilton Mill-Site Number:8400055 Dacula Georgia 30019
DC Research Works-Site Number:8400016 Marietta Georgia 30060
North Georgia Clinical Research-Site Number:8400025 Woodstock Georgia 30189
Johns Hopkins University (Asthma and Allergy Center)-Site Number:8400012 Baltimore Maryland 21224
Asthma Allergy & Sinus Center-Site Number:8400038 White Marsh Maryland 21162
Michigan Medicine (University of Michigan)-Site Number:8400050 Ann Arbor Michigan 48109
Mayo Clinic Lanmark Center 2-46-Site Number:8400065 Rochester Minnesota 55905
Midwest Chest Consultants, P.C.-Site Number:8400011 Saint Charles Missouri 63301
Washington University School of Medicine-Site Number:8400004 St Louis Missouri 63104
Sierra Clinical Research-Site Number:8400035 Las Vegas Nevada 89106
Va Western New York Healthcare-Site Number:8400067 Buffalo New York 14215
IMA Clinical Research, LLC-Site Number:8400070 New York New York 10036
The University of North Carolina at Chapel Hill - Division of Pulmonary and Critical Care Medicine-Site Number:8400019 Chapel Hill North Carolina 27514
American Health Research-Site Number:8400061 Charlotte North Carolina 28277
Duke Asthma, Allergy and Airway Center-Site Number:8400064 Durham North Carolina 27705
Accellacare-Site Number:8400052 Wilmington North Carolina 28401
Southeastern Research Center-Site Number:8400060 Winston-Salem North Carolina 27103-4027
Midwest Pulmonary and Sleep Research Center-Site Number:8400040 Dayton Ohio 45459
Aventiv Research, Inc-Site Number:8400024 Dublin Ohio 43016
OK Clinical Research-Site Number:8400005 Edmond Oklahoma 73034
Velocity Clinical Research, Medford-Site Number:8400001 Medford Oregon 97504
Jefferson Associates in Internal Medicine-Site Number:8400037 Clairton Pennsylvania 15025
Temple University Hospital-Site Number:8400009 Philadelphia Pennsylvania 19140
Emphysema COPD Research Center, Kaufmann Medical Building-Site Number:8400033 Pittsburgh Pennsylvania 15213
Berks Schuylkill Respiratory Specialists, LTD-Site Number:8400063 Wyomissing Pennsylvania 19610
VitaLink Research-Easley-Site Number:8400022 Easley South Carolina 29640
VitaLink Research- Gaffney-Site Number:8400047 Gaffney South Carolina 29340
VitaLink Research-Greenville-Site Number:8400007 Greenville South Carolina 29615
Clinical Research of Charleston-Site Number:8400044 Mt. Pleasant South Carolina 29464
Clinical Research of Rock Hill-Site Number:8400046 Rock Hill South Carolina 29732
VitaLink Research - Spartanburg-Site Number:8400048 Spartanburg South Carolina 29303
Clinical Trials Center of Middle Tennessee-Site Number:8400073 Franklin Tennessee 37067
Bayer College of Medicine-Site Number:8400018 Houston Texas 77030
Metroplex Pulmonary and Sleep Center-Site Number:8400021 McKinney Texas 75069
Sherman Clinical Research-Site Number:8400027 Sherman Texas 75092
MultiCare Institute for Research and Innovation-Site Number:8400036 Tacoma Washington 98405
Allergy, Asthma & Sinus Center, S.C.-Site Number:8400008 Greenfield Wisconsin 53228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 224 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03930732, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2024 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03930732 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →